Paid Clinical Trials Pittsburgh

Discover 1,248 paid clinical trials in Pittsburgh, Pennsylvania. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter

Filter results

Results: 1,248

BomedemstatA Study to Evaluate Safety and Efficacy of Bomedemstat (MK-3543-017)

Recruiting

PHASE3

Sponsor:

Merck Sharp & Dohme LLC

Location:

Pittsburgh PA, Ann Arbor MI

Code:

NCT06351631

Conditions

Thrombocythemia, Essential

Primary Myelofibrosis

Myelofibrosis

Post-polycythemia Vera Myelofibrosis

Post-essential Thrombocythemia Myelofibrosis

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Bomedemstat

TransplantationLung and Bone Marrow Transplantation for Lung and Bone Marrow Failure

Recruiting

PHASE1

PHASE2

Sponsor:

Paul Szabolcs

Location:

Pittsburgh PA

Code:

NCT03500731

Conditions

Idiopathic Pulmonary Fibrosis

Emphysema or COPD

Eligibility Criteria

Sex: All

Age: 18 - 60

Healthy Volunteers: Not accepted

Interventions

CD3/CD19 negative hematopoietic stem cells

Rituximab

Alemtuzumab

Fludarabine

Thiotepa

Axatilimab & CorticosteroidsA Study to Evaluate Axatilimab and Corticosteroids as Initial Treatment for Chronic Graft-Versus-Host Disease

Recruiting

PHASE3

Sponsor:

Incyte Corporation

Location:

Morgantown WV, Hamilton, Detroit MI, Torontoshow 10 more

Code:

NCT06585774

Conditions

Chronic Graft-versus-host-disease

Eligibility Criteria

Sex: All

Age: 12+

Healthy Volunteers: Not accepted

Interventions

INCA034176

Placebo

Corticosteroids

Single vs. MultipleComparison of the Outcomes of Single vs Multiple Arterial Grafts in Women

Recruiting

Sponsor:

Weill Medical College of Cornell University

Location:

Pittsburgh PA, Zanesville OH, Cleveland OH, Columbus OHshow 45 more

Code:

NCT04124120

Conditions

Heart Diseases

Coronary Artery Disease

Coronary Artery Bypass Grafting

Eligibility Criteria

Sex: Female

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Single arterial graft

Multiple arterial grafting

NNC0487-0111A Research Study Comparing How Well Different Doses of the Medicine NNC0487-0111 Lower Blood Sugar in People With Type 2 Diabetes

Recruiting

PHASE2

Sponsor:

Novo Nordisk A/S

Location:

Pittsburgh PA, Hyattsville MD, Oxon Hill MD, Troy MIshow 20 more

Code:

NCT06542874

Conditions

Type 2 Diabetes (T2D)

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

NNC0487-0111 subcutanous

Placebo (NNC0487-0111 subcutanous)

NNC0487-0111 oral

Placebo (NNC0487-0111 oral)

Harmony TPVHarmony TPV Post-Approval Study

Recruiting

Sponsor:

Medtronic Cardiovascular

Location:

Pittsburgh PA, Cleveland OH, Charlottesville VA, Baltimore MDshow 17 more

Code:

NCT05077774

Conditions

Congenital Heart Disease

Tetrology of Fallot

RVOT Anomaly

Pulmonary Regurgitation

Eligibility Criteria

Sex: All

Age: 0 - 70+

Healthy Volunteers: Not accepted

Interventions

Harmony TPV System

MedtronicMedtronic Terminate AF Study

Recruiting

Sponsor:

Medtronic Cardiac Surgery

Location:

Pittsburgh PA, Toledo OH, Wynnewood PA, Norfolk VAshow 10 more

Code:

NCT03546374

Conditions

Persistent Atrial Fibrillation

Longstanding Persistent Atrial Fibrillation

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Surgical Ablation

Cardioblate and Cryoflex hand held devices

Chemotherapy with Endocrine TherapyEvaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25

Recruiting

PHASE3

Sponsor:

NRG Oncology

Location:

Pittsburgh PA, Bryn Mawr PA, Jefferson Hills PA, Monroeville PAshow 715 more

Code:

NCT05879926

Conditions

Breast Cancer

Eligibility Criteria

Sex: Female

Age: 18 - 60

Healthy Volunteers: Not accepted

Interventions

Ovarian Function Suppression + Aromatase Inhibitor

Adjuvant Chemotherapy + Ovarian Function Suppression

Lenalidomide & DaratumumabS1803, Lenalidomide +/- Daratumumab/rHuPh20 as Post-ASCT Maintenance for MM w/MRD to Direct Therapy Duration

Recruiting

PHASE3

Sponsor:

SWOG Cancer Research Network

Location:

Wheeling WV, Boardman OH, Morgantown WV, Youngstown OHshow 530 more

Code:

NCT04071457

Conditions

Multiple Myeloma

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

Lenalidomide

Daratumumab/rHuPH20

IMA203 vs. Investigator's ChoiceSUPRAME-ACTengine® IMA203 vs. Investigator's Choice of Treatment in Previously Treated, Unresectable or Metastatic Cutaneous Melanoma

Recruiting

PHASE3

Sponsor:

Immatics US, Inc.

Location:

Pittsburgh PA, Columbus OH, Philadelphia PA, New York NYshow 8 more

Code:

NCT06743126

Conditions

Melanoma, Cutaneous Malignant

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

IMA203

nivolumab plus relatlimab

lifileucel

nivolumab

pembrolizumab